138 related articles for article (PubMed ID: 25311926)
1. The great mimicker: an extensive bone sarcoidosis.
Buteau JP; Asuaje ED; Rousseau É; Ochoa CA; Rizcallah E; Turcotte É; Keu KV
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):364-5. PubMed ID: 25311926
[No Abstract] [Full Text] [Related]
2. False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer.
Montini KM; Tulchinsky M
Clin Nucl Med; 2012 Mar; 37(3):307-10. PubMed ID: 22310266
[No Abstract] [Full Text] [Related]
3. Osseous Sarcoidosis Mimicking Metastatic Cancer on Positron Emission Tomography.
Ashamalla M; Koutroumpakis E; McCarthy L; Hegener P; Grimm R; Mehdi S
J Oncol Pract; 2016 Jul; 12(7):697-8. PubMed ID: 27407163
[No Abstract] [Full Text] [Related]
4. [Sarcoidosis-lymphoma syndrome].
Partanen A; Pukkila S; Jantunen E
Duodecim; 2016; 132(7):661-5. PubMed ID: 27188091
[TBL] [Abstract][Full Text] [Related]
5. Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy.
Ludwig V; Fordice S; Lamar R; Martin WH; Delbeke D
Clin Nucl Med; 2003 Mar; 28(3):176-9. PubMed ID: 12592122
[TBL] [Abstract][Full Text] [Related]
6. Herniation pit mimicking osseous metastasis on 18F-FDG PET/CT in patient with lung cancer.
Yoo SW; Song HC; Oh JR; Kim J; Kang SR; Chong A; Byun BH; Hong SP; Min JJ; Bom HS
Clin Nucl Med; 2012 Jul; 37(7):682-3. PubMed ID: 22691513
[TBL] [Abstract][Full Text] [Related]
7. Imaging cardiac sarcoidosis by cardiac positron emission tomography (PET): a local experience using a high-fat, low-to-no carbohydrate protocol.
Koh AS; Kok TY; Sim DK; Lath N; Tan RS
Ann Acad Med Singap; 2014 Jul; 43(7):383-5. PubMed ID: 25142475
[No Abstract] [Full Text] [Related]
8. ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography for the evaluation of bone metastasis in patients with gastric cancer.
Ma DW; Kim JH; Jeon TJ; Lee YC; Yun M; Youn YH; Park H; Lee SI
Dig Liver Dis; 2013 Sep; 45(9):769-75. PubMed ID: 23831128
[TBL] [Abstract][Full Text] [Related]
9. Flip-flop pattern of skeleton after treatment in a patient with Hodgkin's lymphoma.
Sahiner I; Akkas BE; Demirel BB; Vural GU
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):277-8. PubMed ID: 23578983
[No Abstract] [Full Text] [Related]
10. MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis.
Lu Y; Sweiss NJ
Clin Nucl Med; 2015 Dec; 40(12):973-4. PubMed ID: 26544904
[TBL] [Abstract][Full Text] [Related]
11. Central skeletal sarcoidosis mimicking metastatic disease.
Talmi D; Smith S; Mulligan ME
Skeletal Radiol; 2008 Aug; 37(8):757-61. PubMed ID: 18401580
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/CT Findings of Multifocal Epithelioid Hemangioendotheliomas of the Bones.
Rao M; Chen Y; Huang Z; Zhu Y; Xiao X
Clin Nucl Med; 2015 Oct; 40(10):821-2. PubMed ID: 26018717
[TBL] [Abstract][Full Text] [Related]
13. [Pet imaging in prostate cancer].
Oyama N; Kaneda T; Nakai M; Shioyama R; Matsuta Y; Tanase K; Aoki Y; Miwa Y; Akino H; Yokoyama O; Okazawa H; Fujibayashi Y; Yonekura Y
Hinyokika Kiyo; 2006 Jun; 52(6):503-5. PubMed ID: 16848365
[No Abstract] [Full Text] [Related]
14. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Ng SP; David S; Alamgeer M; Ganju V
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
[TBL] [Abstract][Full Text] [Related]
15. Use of integrated FDG-PET/CT in sarcoidosis.
Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
[TBL] [Abstract][Full Text] [Related]
16. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Paz YE; Bokhari S
Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
[TBL] [Abstract][Full Text] [Related]
17. Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma.
Stokkel MP; van der Hiel B; Olmos RV; Hoefnagel K
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):919-20. PubMed ID: 22286771
[No Abstract] [Full Text] [Related]
18. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
19. Lobular breast carcinoma: a case of rare possible 18F-FDG PET/CT and bone scan false negative.
Maffione AM; Lisato LC; Rasi A; Marzola MC; Colletti PM; Rubello D
Clin Nucl Med; 2015 Feb; 40(2):e134-6. PubMed ID: 24999681
[TBL] [Abstract][Full Text] [Related]
20. Obscured bone metastases after administration of hematopoietic factor on FDG-PET.
Chhabra A; Batra K; Makler PT
Clin Nucl Med; 2006 Jun; 31(6):328-30. PubMed ID: 16714890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
